Developing treatments for cognitive deficits in schizophrenia: The challenge of translation
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Schizophrenia is a life-long debilitating mental disorder affecting tens of millions of people worldwide. The serendipitous discovery of antipsychotics focused pharmaceutical research on developing a better antipsychotic. Our understanding of the disorder has advanced however, with the knowledge that cognitive enhancers are required for patients in order to improve their everyday lives. While antipsychotics treat psychosis, they do not enhance cognition and hence are not antischizophrenics. Developing pro-cognitive therapeutics has been extremely difficult, however, especially when no approved treatment exists. In lieu of stumbling on an efficacious treatment, developing targeted compounds can be facilitated by understanding the neural mechanisms underlying altered cognitive functioning in patients. Equally importantly, these cognitive domains will need to be measured similarly in animals and humans so that novel targets can be tested prior to conducting expensive clinical trials. To date, the limited similarity of testing across species has resulted in a translational bottleneck. In this review, we emphasize that schizophrenia is a disorder characterized by abnormal cognitive behavior. Quantifying these abnormalities using tasks having cross-species validity would enable the quantification of comparable processes in rodents. This approach would increase the likelihood that the neural substrates underlying relevant behaviors will be conserved across species. Hence, we detail cross-species tasks which can be used to test the effects of manipulations relevant to schizophrenia and putative therapeutics. Such tasks offer the hope of providing a bridge between non-clinical and clinical testing that will eventually lead to treatments developed specifically for patients with deficient cognition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Insel, T., Cuthbert, B., Garvey, M., Heinssen, R., Pine, D. S., Quinn, K., Sanislow, C., & Wang, P. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09091379 · Cited by 7,067 · cited 2×
“…relation to schizophrenia—will also be relevant for other disorders or in fact in the NIMH Research Domain Criteria (RDoC) initiative, a new way of classifying psychopathology based on dimensions of functioning (Cuthbert and Insel, 2010; Insel, 2014; Insel et al., 2010; Morris and Cuthbert, 2012).”
BackgroundInsensitivity to future consequences following damage to human prefrontal cortex
Bechara, A., Damasio, A. R., Damasio, H., & Anderson, S. W. (1994) · Cognition · doi:10.1016/0010-0277(94)90018-3 · Cited by 6,128
What are the functional consequences of neurocognitive deficits in schizophrenia?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516
Mnemonic coding of visual space in the monkey's dorsolateral prefrontal cortex
Funahashi, S., Bruce, C. J., & Goldman-Rakic, P. S. (1989) · Journal of Neurophysiology · doi:10.1152/jn.1989.61.2.331 · Cited by 2,685 · cited 1×
“Using this DRT, they were able to demonstrate that increased dorsolateral prefrontal cortex (PFC) firing occurs to cue the location of the to-be-remembered cue and degradation of the firing matches with inaccuracy during choices (Funahashi et al., 1989).”
MethodThe MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity
Nuechterlein, K. H., Green, M. F., Kern, R. S., Baade, L. E., Barch, D. M., Cohen, J. D., Essock, S., Fenton, W. S., Frese, F. J., Gold, J. M., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07010042 · Cited by 2,342
A continuous performance test of brain damage
Rosvold, H. E., Mirsky, A. F., Sarason, I., Bransome, E. D., & Beck, L. H. (1956) · Journal of Consulting Psychology · doi:10.1037/h0043220 · Cited by 2,261
The elusive nature of executive functions: a review of our current understanding.
Jurado, M. B., & Rosselli, M. (2007) · Neuropsychology Review · doi:10.1007/s11065-007-9040-z · Cited by 1,684 · cited 1×
“The cognitive domain of executive functioning is a highly varied domain containing numerous aspects of cognition from problem solving, planning, organization, and initiation of tasks, cognitive flexibility, and the inhibition of inappropriate responses (Ardila, 2008; Jurado and Rosselli, 2007).”
BackgroundAron, A. R., & Poldrack, R. A. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4682-05.2006 · Cited by 1,630 · cited 3×
“In humans, the structures subserving SSRT have been examined in detail (Aron and Poldrack, 2006), while numerous lesion studies in rats have examined structures subserving rat SSRT (Eagle and Baunez, 2010).”
BackgroundResultOn the ability to inhibit simple and choice reaction time responses: A model and a method.
Logan, G. D., Cowan, W. B., & Davis, K. A. (1984) · Journal of Experimental Psychology: Human Perception and Performance · doi:10.1037/0096-1523.10.2.276 · Cited by 1,542
The NIMH Research Domain Criteria (RDoC) Project: Precision Medicine for Psychiatry
Insel, T. R. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14020138 · Cited by 1,472 · cited 2×
“…relation to schizophrenia—will also be relevant for other disorders or in fact in the NIMH Research Domain Criteria (RDoC) initiative, a new way of classifying psychopathology based on dimensions of functioning (Cuthbert and Insel, 2010; Insel, 2014; Insel et al., 2010; Morris and Cuthbert, 2012).”
Background
Cited by
Aref-Adib, G., McCloud, T., Ross, J., O'Hanlon, P., Appleton, V., Rowe, S., Murray, E., Johnson, S., & Lobban, F. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30302-x · Cited by 118
A Review of Oxytocin’s Effects on the Positive, Negative, and Cognitive Domains of Schizophrenia
Feifel, D., Shilling, P. D., & MacDonald, K. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.07.025 · Cited by 110
Investigating the mechanism(s) underlying switching between states in bipolar disorder
Young, J. W., & Dulcis, D. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.019 · Cited by 68
“Numerous laboratory-based cross-species tests of cognitive state exist however (Young and Geyer, 2014) and could be used to quantify changes in behavior of patients during switches from one mood state to another.”
BackgroundMethodSelf-citation
Metadata
- Authors
- Young, J., & Geyer, M.
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2014-12-16
- Volume
- 29
- Issue
- 2
- Pages
- 178-196
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2090522879
- Cited by
- 110
- References
- 54
- FWCI
- 10.33
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Developing treatments for cognitive deficits in schizophrenia: The challenge of translation. https://app.cochat.ai/papers/10.1177/0269881114555252
- The paper
- Young, J., & Geyer, M. (2015). Developing treatments for cognitive deficits in schizophrenia: The challenge of translation. Journal of Psychopharmacology. https://doi.org/10.1177/0269881114555252
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.